sec filing
CR
NASDAQ · CRBP
Corbus Pharmaceuticals Holdings, Inc.
Healthcare · Biotechnology
$7.48
Up+$0.22 (+3.03%)
Updated Sep 19, 2026, 12:45 PM
SID Score
2.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 121.59M
- P/E ratio
- -2.05
- Dividend yield
- 0.00%
- 52-week range
- $6.33 – $12.88
- Volume
- 1.16M
- Avg. volume
- 372.45K
Price performance
CRBP price history
1M range · 20 trading sessions · Daily adjusted prices
CRBP closed at $7.48 after 20 trading sessions, down 27.94% for the selected period.
- Last close
- $7.48
- Period change
- -27.94%
- Period low
- $6.92
- Period high
- $11.48
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $7.22 | $7.67 | $7.1537 | $7.48 | 1.16M |
| Sep 17, 2026 | $7.26 | $7.38 | $7.03 | $7.26 | 992.87K |
| Sep 16, 2026 | $6.86 | $7.50 | $6.82 | $7.26 | 1.23M |
| Sep 15, 2026 | $8.08 | $8.08 | $6.325 | $6.92 | 3.76M |
| Sep 14, 2026 | $7.93 | $8.70 | $7.66 | $8.08 | 8.4M |
| Sep 11, 2026 | $8.38 | $8.495 | $7.95 | $8.12 | 2.35M |
| Sep 10, 2026 | $8.75 | $8.79 | $8.21 | $8.24 | 646.76K |
| Sep 9, 2026 | $10.60 | $10.715 | $8.845 | $8.86 | 1M |
| Sep 8, 2026 | $11.07 | $11.07 | $10.31 | $10.595 | 915.46K |
| Sep 4, 2026 | $11.37 | $11.445 | $11.055 | $11.08 | 222.61K |
| Sep 3, 2026 | $11.52 | $11.60 | $11.22 | $11.46 | 475.36K |
| Sep 2, 2026 | $11.27 | $11.56 | $10.60 | $11.48 | 664.45K |
| Sep 1, 2026 | $10.81 | $11.37 | $10.575 | $11.28 | 901.3K |
| Aug 31, 2026 | $10.86 | $11.00 | $10.39 | $10.91 | 473.59K |
| Aug 28, 2026 | $11.13 | $11.29 | $10.745 | $10.91 | 584.32K |
| Aug 27, 2026 | $11.28 | $11.45 | $11.11 | $11.13 | 325.89K |
| Aug 26, 2026 | $11.36 | $11.5456 | $10.96 | $11.30 | 392.19K |
| Aug 25, 2026 | $10.90 | $11.35 | $10.79 | $11.31 | 1.28M |
| Aug 24, 2026 | $10.20 | $10.88 | $9.68 | $10.69 | 1.31M |
| Aug 21, 2026 | $9.97 | $10.415 | $9.895 | $10.38 | 604.02K |
Latest CRBP news
The latest Smart Investors Daily articles mentioning CRBP.
Stock researchResearch & News · Competitors
Loading stock research…